# Carvedilol in Treating Hypoglycemia Unawareness

> **NCT03538015** · PHASE2 · TERMINATED · sponsor: **Owen Chan, PhD** · enrollment: 1 (actual)

## Conditions studied

- Hypoglycemia Unawareness

## Interventions

- **DRUG:** Carvedilol 3.125 mg
- **DRUG:** Carvedilol 2.5 mg
- **DRUG:** Placebo capsule

## Key facts

- **NCT ID:** NCT03538015
- **Lead sponsor:** Owen Chan, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-22
- **Primary completion:** 2020-08-10
- **Final completion:** 2020-08-10
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Sponsor was impacted by COVID-19 and did not have sufficient funds to continue.
- **Last updated:** 2020-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03538015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03538015, "Carvedilol in Treating Hypoglycemia Unawareness". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03538015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*